Faculty of 1000 evaluation for Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing.

James Crowe
  • October 2007, Faculty of 1000, Ltd.
  • DOI: 10.3410/f.1093763.548682

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.3410/f.1093763.548682

The following have contributed to this page: Dr James E Crowe